These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 24595021)

  • 1. Select neurocognitive impairment in HIV-infected women: associations with HIV viral load, hepatitis C virus, and depression, but not leukocyte telomere length.
    Giesbrecht CJ; Thornton AE; Hall-Patch C; Maan EJ; Côté HC; Money DM; Murray M; Pick N
    PLoS One; 2014; 9(3):e89556. PubMed ID: 24595021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of cigarette smoking with viral immune and cognitive function in human immunodeficiency virus-seropositive women.
    Wojna V; Robles L; Skolasky RL; Mayo R; Selnes O; de la Torre T; Maldonado E; Nath A; Meléndez LM; Lasalde-Dominicci J
    J Neurovirol; 2007 Dec; 13(6):561-8. PubMed ID: 18097887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria.
    Akolo C; Royal W; Cherner M; Okwuasaba K; Eyzaguirre L; Adebiyi R; Umlauf A; Hendrix T; Johnson J; Abimiku A; Blattner WA
    J Neurovirol; 2014 Aug; 20(4):380-7. PubMed ID: 24927825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between short leukocyte telomere length and HIV infection in a cohort study: No evidence of a relationship with antiretroviral therapy.
    Zanet DL; Thorne A; Singer J; Maan EJ; Sattha B; Le Campion A; Soudeyns H; Pick N; Murray M; Money DM; Côté HC;
    Clin Infect Dis; 2014 May; 58(9):1322-32. PubMed ID: 24457340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the telomere length associated with neurocognitive disabilities in HIV-1-infected subjects?
    Araújo ML; Duarte W; Oliveira ACP; Gascón MRP; Fonseca LAM; Paiva RMA; Santana B; Calado RT; Casseb J
    Rev Inst Med Trop Sao Paulo; 2018; 60():e16. PubMed ID: 29694602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of neurocognitive effect of hepatitis C infection in HIV-coinfected people.
    Clifford DB; Vaida F; Kao YT; Franklin DR; Letendre SL; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; Grant I; Heaton RK;
    Neurology; 2015 Jan; 84(3):241-50. PubMed ID: 25503616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria.
    Royal W; Cherner M; Carr J; Habib AG; Akomolafe A; Abimiku A; Charurat M; Farley J; Oluyemisi A; Mamadu I; Johnson J; Ellis R; McCutchan JA; Grant I; Blattner WA
    J Neurovirol; 2012 Jun; 18(3):191-9. PubMed ID: 22528480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurocognitive impairment with hepatitis C and HIV co-infection in Southern Brazil.
    de Almeida SM; de Pereira AP; Pedroso MLA; Ribeiro CE; Rotta I; Tang B; Umlauf A; Franklin D; Saloner RG; Batista MGR; Letendre S; Heaton RK; Ellis RJ; Cherner M;
    J Neurovirol; 2018 Jun; 24(3):339-349. PubMed ID: 29516346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shorter telomere length - A potential susceptibility factor for HIV-associated neurocognitive impairments in South African women [corrected].
    Malan-Müller S; Hemmings SM; Spies G; Kidd M; Fennema-Notestine C; Seedat S
    PLoS One; 2013; 8(3):e58351. PubMed ID: 23472184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations between Cognition, Gender and Monocyte Activation among HIV Infected Individuals in Nigeria.
    Royal W; Cherner M; Burdo TH; Umlauf A; Letendre SL; Jumare J; Abimiku A; Alabi P; Alkali N; Bwala S; Okwuasaba K; Eyzaguirre LM; Akolo C; Guo M; Williams KC; Blattner WA
    PLoS One; 2016; 11(2):e0147182. PubMed ID: 26829391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of hepatitis C, HIV, and methamphetamine dependence on neuropsychological performance: biological correlates of disease.
    Letendre SL; Cherner M; Ellis RJ; Marquie-Beck J; Gragg B; Marcotte T; Heaton RK; McCutchan JA; Grant I;
    AIDS; 2005 Oct; 19 Suppl 3():S72-8. PubMed ID: 16251831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychological performance in patients with asymptomatic HIV-1 infection.
    Martínez-Banfi M; Vélez JI; Perea MV; García R; Puentes-Rozo PJ; Mebarak Chams M; Ladera V
    AIDS Care; 2018 May; 30(5):623-633. PubMed ID: 29411628
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.
    Wright EJ; Grund B; Robertson K; Brew BJ; Roediger M; Bain MP; Drummond F; Vjecha MJ; Hoy J; Miller C; Penalva de Oliveira AC; Pumpradit W; Shlay JC; El-Sadr W; Price RW;
    Neurology; 2010 Sep; 75(10):864-73. PubMed ID: 20702792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression.
    Cysique LA; Brew BJ
    J Neurovirol; 2011 Apr; 17(2):176-83. PubMed ID: 21416169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive impairment in HIV-1 clade C- versus B-infected individuals in Southern Brazil.
    de Almeida SM; Ribeiro CE; de Pereira AP; Badiee J; Cherner M; Smith D; Maich I; Raboni SM; Rotta I; Barbosa FJ; Heaton RK; Umlauf A; Ellis RJ
    J Neurovirol; 2013 Dec; 19(6):550-6. PubMed ID: 24277437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral biomarkers do not correlate with cognitive impairment in highly active antiretroviral therapy-treated subjects with human immunodeficiency virus type 1 infection.
    Sun B; Abadjian L; Rempel H; Calosing C; Rothlind J; Pulliam L
    J Neurovirol; 2010 Mar; 16(2):115-24. PubMed ID: 20307252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depression and neurocognitive performance in Portuguese patients infected with HIV.
    Bragança M; Palha A
    AIDS Behav; 2011 Nov; 15(8):1879-87. PubMed ID: 21598031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic shift of env V3 loop viral sequences in patients with HIV-associated neurocognitive disorder during antiretroviral therapy.
    Eggers C; Müller O; Thordsen I; Schreiber M; Methner A
    J Neurovirol; 2013 Dec; 19(6):523-30. PubMed ID: 24101298
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms and neurocognitive performance among HIV-infected women.
    Fialho RM; Pereira M; Mendonça N; Ouakinin S
    Women Health; 2013; 53(2):117-34. PubMed ID: 23517511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive functioning in acute or early HIV infection.
    Moore DJ; Letendre SL; Morris S; Umlauf A; Deutsch R; Smith DM; Little S; Rooney A; Franklin DR; Gouaux B; Leblanc S; Rosario D; Fennema-Notestine C; Heaton RK; Ellis RJ; Atkinson JH; Grant I;
    J Neurovirol; 2011 Feb; 17(1):50-7. PubMed ID: 21165782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.